COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
Both manufacturing facilities are based out of Benguluru, India
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
Expanding diagnostics footprint in East India
Alopecia areata usually presents as a few small bald patches in the head
_256_384.png)
Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities
Acceptance based on results from the phase 3 KEYNOTE-091 trial
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Subscribe To Our Newsletter & Stay Updated
